New glucose monitor put to the test in diabetes study

NCT ID NCT05806554

First seen Jan 11, 2026 · Last updated May 03, 2026 · Updated 17 times

Summary

This study checked how accurately the True Vie I3 continuous glucose monitor (CGM) measures blood sugar levels. 159 adults with type 1 or type 2 diabetes wore the device to see if it meets FDA standards. The goal was to confirm the monitor's performance for helping people manage their diabetes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Atlanta Diabetes Associates

    Atlanta, Georgia, 30318, United States

  • Diablo Clinical Research

    Walnut Creek, California, 94598, United States

  • Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

    Ulm, D-89081, Germany

  • PSHI Praxis GmbH

    Mainz, 55128, Germany

  • Rainier Clinical Research Center

    Renton, Washington, 98057, United States

  • Woodland Research Northwest

    Rogers, Arkansas, 72758, United States

Conditions

Explore the condition pages connected to this study.